Following FDA regulatory action, CDC has taken steps to simplify COVID-19 vaccine recommendations and allow more flexibility for people at higher risk who want the option to receive an additional COVID-19 vaccine dose.
CDC’s Advisory Committee on Immunization Practices (ACIP) met today to discuss these COVID-19 vaccine recommendation changes, and the associated implications and implementation. Although there was no vote at this meeting, ACIP members expressed their support for these recommendations.
These changes include:
Individuals ages 6 years and older who have already received an updated mRNA vaccine do not need to take any action unless they are 65 years or older or immunocompromised.
For young children, multiple doses continue to be recommended and will vary by age, vaccine, and which vaccines were previously received.
Alternatives to mRNA COVID-19 vaccines remain available for people who cannot or will not receive an mRNA vaccine. CDC’s recommendations for use of (monovalent) Novavax or Johnson & Johnson’s Janssen COVID-19 vaccines were not affected by the changes made today.
CDC and ACIP will continue to monitor COVID-19 disease levels and vaccine effectiveness in the months ahead and look forward to additional discussion around potential updates this fall.
In the coming days, CDC will update it's website, including the Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States and additional COVID-19 vaccine webpages.
NASW’s national Connect to End COVID-19 campaign, a CDC-funded initiative to support social workers and their clients in informed vaccine decision-making (2021-2024).
Learn about Connect to End COVID-19
Social workers support informed decision making about important healthcare choices, provide health information from credible sources, and address mental and behavioral health concerns arising as a result of this public health crisis.
Get coronavirus resources